C-Reactive Protein Levels and Cognitive Decline following Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

• Published in: Brain sciences Vol. 13; no. 7; p. 1082
• Main Authors: Wang, Likun, Yang, Lining, Liu, Haiyan, Pu, Juncai, Li, Yi, Tang, Lu, Chen, Qing, Pu, Fang, Bai, Dingqun
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.07.2023; MDPI
• Subjects: C-reactive protein; cognition; Cognition & reasoning; Cognitive ability; cognitive decline; Cohort analysis; Confidence intervals; Dementia; inflammatory factor; Ischemia; ischemic stroke; Knowledge management; Medical research; Medicine, Experimental; Meta-analysis; Proteins; Stroke; Stroke (Disease); Systematic Review; China; United States > US; meta-analysis; inflammatory factor; C-reactive protein; cognition; cognitive decline; ischemic stroke
• ISSN: 2076-3425; 2076-3425
• DOI: 10.3390/brainsci13071082

Cognitive decline (CD) is devastating with a high incidence in patients after stroke. Although some studies have explored underlying associations between C-reactive protein (CRP) levels and cognitive decline after stroke, consistent results have not been obtained. Therefore, this meta-analysis aimed to explore whether or not higher levels of C-reactive proteins were associated with an increased risk of cognitive decline after stroke. To this end, PubMed, Embase, the Cochrane Library, and Web of Science were searched for eligible studies, and pooled effect sizes from eligible studies were calculated using random effect models. Furthermore, subgroups were established and meta-regression analyses were performed to explain the causes of heterogeneity. Eventually, nine studies with 3893 participants were included. Our statistical results suggested that the concentrations of peripheral CRP may be significantly increased for CD patients after stroke, compared to those of non-CD patients. Subgroup analyses showed that CRP was higher in CD than that in non-CD patients when the mini-mental state examination was used. A higher level of CRP in the acute phase of ischemic stroke may suggest an increased risk of CD after stroke. However, these results should be cautiously interpreted because of the limited sample sizes and the diversity of potential confounders in the studies included in this meta-analysis.